Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 6,276–6,300 of 27,380 studies, newest first · page 252 of 1096.

August 2024 25

  1. 2024-08-22

    Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2

    ✓ Peer-reviewed TREM2 and immune genetics Proceedings of the National Academy of Sciences of the United States of America

    Key finding: Comparing macrophage heterogeneity during MASH progression vs regression, we identified specific macrophage subpopulations that are critical for MASH/fibrosis resolution. +3 more findings

  2. 2024-08-21

    Racial and ethnic disparities in potentially inappropriate medication use in patients with dementia

    ✓ Peer-reviewed Disparities Journal of the American Geriatrics Society

    Key finding: Compared to White participants, Black, Hispanic, and Asian participants reported taking fewer total medications (incidence rate ratio [IRR] ± standard error[SE] = 0.903 ± 0.017, 0.875 ± 0.021, and 0.912 ± 0.041, respectively, all p < 0.01). +4 more findings

  3. 2024-08-21

    The impact of physical exercise on neuroinflammation mechanism in Alzheimer's disease

    ✓ Peer-reviewed Inflammation and the immune system Frontiers in aging neuroscience

    Key finding: The findings underscore the potential of integrating physical exercise into comprehensive AD management strategies. +3 more findings

  4. 2024-08-21

    Accelerometer-derived 'weekend warrior' physical activity pattern and brain health

    ✓ Peer-reviewed Long-term cohort studies Nature aging

    Key finding: However, whether the 'weekend warrior' pattern, characterized by concentrated moderate-to-vigorous PA (MVPA) over 1-2 days, is associated with brain health is unclear. +3 more findings

  5. 2024-08-20

    C9orf72 dipeptides activate the NLRP3 inflammasome

    ✓ Peer-reviewed Inflammation and the immune system Brain communications

    Key finding: Poly-glycine-arginine also activated the inflammasome in organotypic hippocampal slice cultures, and immunofluorescence imaging demonstrated formation of inflammasome specks in response to poly-glycine-arginine. +1 more finding

  6. 2024-08-19

    Performance of plasma p-tau217 for the detection of amyloid-β positivity in a memory clinic cohort using an electrochemiluminescence immunoassay

    ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy

    Key finding: Of 108 participants (age: 69 ± 6.5 years; 54.6% female) with paired samples obtained at time of LP, 64.8% (n = 70/108) had Aβ pathology detected (35 with Mild Cognitive Impairment and 35 with mild dementia). +1 more finding

  7. 2024-08-17

    Single-Nucleus Landscape of Glial Cells and Neurons in Alzheimer's Disease

    ✓ Peer-reviewed Genetics Molecular neurobiology

    Key finding: Alzheimer's disease (AD) is a neurodegenerative disease with a projected significant increase in incidence. +3 more findings

  8. 2024-08-16

    Peripheral hearing loss at age 70 predicts brain atrophy and associated cognitive change

    ✓ Peer-reviewed Risk factors Journal of neurology, neurosurgery, and psychiatry

    Key finding: 111 out of 287 participants had hearing impairment. +4 more findings

  9. 2024-08-16

    Single-nucleus multiome analysis of human cerebellum in Alzheimer's disease-related dementia

    ⚠ Preprint — not yet peer-reviewed Genetics Research square

    Key finding: Using peak-to-gene linkage analysis, we identified 431,834 significant linkages between gene expression and cell subtype-specific chromatin accessibility regions enriched for candidate cis-regulatory elements (cCREs). +1 more finding

    Scored 22 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  10. 2024-08-16

    Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy

    ✓ Peer-reviewed Genetics Molecular neurodegeneration

    Key finding: Our analysis of common SNVs and indels confirmed known genetic loci at MAPT, MOBP, STX6, SLCO1A2, DUSP10, and SP1, and further uncovered novel signals in APOE, FCHO1/MAP1S, KIF13A, TRIM24, TNXB, and ELOVL1. +4 more findings

  11. 2024-08-16

    Regional variation in diagnostic intensity of dementia among older U.S. adults: An observational study

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: Crude new ADRD diagnosis rate ranged from 1.7 to 5.4 per 100 across HRRs. +4 more findings

  12. 2024-08-16

    Prevalence of dementia diagnosis in Sweden by geographical region and sociodemographic subgroups: a nationwide observational study

    ✓ Peer-reviewed Risk factors The Lancet Regional Health - Europe

    Key finding: At the end of 2022, 3.7% (92,293/2,483,798) of people aged ≥62 years in Sweden had a dementia diagnosis from specialist care or drug prescriptions and varied from 0.6% in ages 62-69 to 14.8% in ages ≥90. +4 more findings

  13. 2024-08-16

    Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study

    ✓ Peer-reviewed Biomarkers The Lancet regional health. Europe

    Key finding: Higher levels of P-tau181 (HR = 1.32 [95% CI: 1.17-1.51]), NfL (HR = 1.19 [95% CI: 1.03-1.36]), and GFAP (HR = 1.36 [95% CI: 1.22-1.52]), and a lower Aβ42/Aβ40 ratio (HR = 0.80 [95% CI: 0.68-0.95]) were associated with an increased risk of progressing to clinically-diagnosed DAT. +1 more finding

  14. 2024-08-15

    Tau pathology mediated the plasma biomarkers and cognitive function in patients with mild cognitive impairment

    ✓ Peer-reviewed Biomarkers Experimental gerontology

    Key finding: Glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) are putative non-amyloid biomarkers indicative of ongoing inflammatory and neurodegenerative disease processes. +1 more finding

  15. 2024-08-15

    Dose-response relationship between computerized cognitive training and cognitive improvement

    ✓ Peer-reviewed Cognitive tests and assessment NPJ digital medicine

    Key finding: A mixed-effects model revealed significant Cognitive Index increases across most dose groups before reaching the optimal dose. +1 more finding

  16. 2024-08-14

    Enhancing dementia risk screening with GAN-synthesized periodontal examination and general blood test data

    ✓ Peer-reviewed Biomarkers Frontiers in neurology

    Key finding: This study used measured data from 108 participants and the synthesized data generated from the measured data. +4 more findings

  17. 2024-08-14

    Proteomics identifies potential immunological drivers of postinfection brain atrophy and cognitive decline

    ✓ Peer-reviewed Biomarkers Nature aging

    Key finding: Infections have been associated with the incidence of Alzheimer disease and related dementias, but the mechanisms responsible for these associations remain unclear. +3 more findings

  18. 2024-08-14
  19. 2024-08-13

    Divergent Mortality Patterns Associated With Dementia in the United States: 1999-2020

    ✓ Peer-reviewed Disparities The primary care companion for CNS disorders

    Key finding: Among these, 85.5% were non-Hispanic (NH) white, 8% NH black, 4.34% Hispanic or Latino, 1.6% NH Asian or Pacific Islander, and 0.3% NH American Indian or Alaska Native adults. +4 more findings

  20. 2024-08-13

    Cortical neurodegeneration caused by Psen1 mutations is independent of Aβ

    ✓ Peer-reviewed Risk genes beyond APOE Proceedings of the National Academy of Sciences of the United States of America

    Key finding: Our findings demonstrate that Psen1 mutations cause age-dependent neurodegeneration independent of Aβ, providing further support for a loss-of-function pathogenic mechanism underlying PSEN mutations.

  21. 2024-08-13

    P-tau217 as a Reliable Blood-Based Marker of Alzheimer's Disease

    ✓ Peer-reviewed Biomarkers Biomedicines

    Key finding: Phosphorylated tau (p-tau) has shown greater promise in reflecting amyloid pathology as evidenced by CSF and PET positivity. +4 more findings

  22. 2024-08-13

    Educational disparities in brain health and dementia across Latin America and the United States

    ✓ Peer-reviewed Disparities Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The results underscore the impact of education on brain structure and function in LA, highlighting the importance of incorporating educational factors into diagnosing, care, and prevention, and emphasizing the need for global diversity in research. +4 more findings

  23. 2024-08-12

    Impaired cellular copper regulation in the presence of ApoE4

    ✓ Peer-reviewed Genetics Journal of neurochemistry

    Key finding: Exposure of ApoE target replacement (TR) astrocytes (immortalised astrocytes from APOE knock-in mice) to elevated copper concentrations resulted in exacerbated copper accumulation in ApoE4- compared to ApoE2- and ApoE3-TR astrocytes.

  24. 2024-08-12

    Epidemiology of Homebound Population Among Beneficiaries of a Large National Medicare Advantage Plan

    ✓ Peer-reviewed Health systems and care delivery Annals of Internal Medicine

    Key finding: In 2022, the overall prevalence of homebound beneficiaries was 22.0% (8.4% of beneficiaries were homebound, and 13.6% were semihomebound). +4 more findings

  25. 2024-08-11

    Pathogenesis of Cerebral Small Vessel Disease: Role of the Glymphatic System Dysfunction

    ✓ Peer-reviewed Vascular contributions International journal of molecular sciences

    Key finding: CSVD may result from dysfunction in the glymphatic system (GS). +1 more finding

Browse the library by subject, with the full score breakdown →